Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

How thalidomide makes its mark

Drug's effects on embryonic blood-vessel growth may be the source of malformed limbs.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout


  1. Therapontos, C., Erskine, L., Gardner, E. R., Figg, W. D. & Vargesson, N. Proc. Natl Acad. Sci. USA doi:10.1073/pnas.0901505106 (2009).

  2. Knobloch, J., Shaughnessy, J. D. Jr & Ruther, U. FASEB J. 21, 1410–1421 (2007).

    Article  CAS  Google Scholar 

Download references


Related links

Related links

Related links in Nature Research

Nature Reviews Cancer Focus on Targeting Angiogenesis

Related external links

National Toxicology Program: Thalidomide

World Health Organizatino: Use of thalidomide in leprosy

Neil Vargesson

Jürgen Knobloch

Lewis Holmes

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ledford, H. How thalidomide makes its mark. Nature (2009).

Download citation

  • Published:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing